TYRA BIOSCIENCES, INC. TYRA 深 滬
已收盤 08-01 16:00:00 美东时间
10.37
-0.560
-5.12%
華盛通- 最 高10.815
- 今 開10.78
- 成交量 28.39万股
- 最 低 10.33
- 昨 收 10.93
- 總市值 5.51亿
- 52周最高 29.60
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 6.42
- 委 比 -35.26%
- 總股本 5317.80万
- 歷史最高 31.36
- 量 比 1.37
- 振 幅 4.44%
- 歷史最低 4.93
- 每 手 1
- 風險率 5.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Tyra Biosciences Says Late-Breaking Abstract On TYRA-300 Preclinical Results Accepted For Presentation At ENDO 2025
Tyra Biosciences, Inc. (NASDAQ:TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR)
07-09 04:09
美股大行评级 | 潜在涨幅83.3%！Robinhood获Keybanc升目标价至110美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners：维持再鼎医药(ZLAB)"跑赢大市"评级，目标价从73美元升至75美元</p> <p>• 美银证券：维持BioCryst Pharma(BCRX)"买入"评级，目标价从13美元升至15美元
07-02 09:54
HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $30 Price Target
HC Wainwright & Co. analyst Mitchell Kapoor reiterates Tyra Biosciences (NASDAQ:TYRA) with a Buy and maintains $30 price target.
07-01 19:37
Tyra Biosciences Independent Director Gilla Kaplan Sells 58% Of Holding
Some Tyra Biosciences, Inc. (NASDAQ:TYRA) shareholders may be a little concerne...
06-19 18:54
Piper Sandler Assumes Tyra Biosciences at Overweight, Announces Price Target of $33
Piper Sandler analyst Allison Bratzel assumes Tyra Biosciences (NASDAQ:TYRA) with a Overweight rating and announces Price Target of $33.
05-21 23:05
Tyra Biosciences Q1 EPS $(0.47) Beats $(0.48) Estimate
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.48) by 2.08 percent. This is a 34.29 percent decrease over losses of $(0.35) per share from
05-09 04:53
Tyra Biosciences Advances Precision Medicine Pipeline
Tyra Bioscience, Inc ( ($TYRA) ) has released its Q4 earnings. Here is a breakd...
03-29 11:54
美股大行评级 | 潜在涨幅224%！Ultragenyx制药获Piper Sandler上调目标价至140美元，维持“超配”评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1085846677098434561.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Piper Sandler：维持Ultragenyx制药(RARE)"超配"评级，目标价从135美元升至140美元</p> <p>• Leerink Partners：维持ARS Pharmaceuticals(SPRY)
01-14 09:51
美股大行评级 | 什么信号？苹果遭机构下调评级至"卖出"，目标价降至188美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1083672797687590912.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持U.S. Goldmining Inc.(USGO)"买入"评级，目标价从24美元升至26.5美元</p> <p>• TD Cowen：上调GeneDx目标价从75美元至
01-08 09:30
